Prepared Retirement Institute’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.5M Buy
5,962
+6
+0.1% +$1.29K 0.64% 29
2026
Q1
$1.3M Sell
5,956
-200
-3% -$44.4K 0.64% 26
2025
Q4
$1.41M Sell
6,156
-60
-1% -$13.7K 0.71% 24
2025
Q3
$1.44M Sell
6,216
-52
-0.8% -$10.6K 0.75% 23
2025
Q2
$1.16M Sell
6,268
-194
-3% -$36.1K 0.69% 25
2025
Q1
$1.35M Sell
6,462
-398
-6% -$77.4K 0.86% 22
2024
Q4
$1.22M Buy
6,860
+81
+1% +$14.9K 0.7% 22
2024
Q3
$1.34M Buy
6,779
+73
+1% +$13.6K 0.81% 21
2024
Q2
$1.15M Sell
6,706
-5
-0.1% -$828 0.76% 20
2024
Q1
$1.22M Sell
6,711
-1,599
-19% -$276K 0.91% 18
2023
Q4
$1.29M Buy
+8,310
New +$1.21M 0.96% 18

Other funds holding ABBV

Prepared Retirement Institute's ABBV Position: Q2 2026 in Review

Prepared Retirement Institute increased its AbbVie (ABBV) stake by 0.1% in Q2 2026, buying an estimated $1.29K and bringing the position to 5,962 shares worth $1.5M. The position accounts for 0.64% of the portfolio, ranked #29.

Prepared Retirement Institute first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Prepared Retirement Institute held 5,962 shares of AbbVie worth $1.5M as of Q2 2026.
  • Prepared Retirement Institute bought 6 AbbVie shares in Q2 2026, an estimated $1.29K.
  • AbbVie made up 0.64% of Prepared Retirement Institute's portfolio in Q2 2026, its #29 holding.
  • Prepared Retirement Institute first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Prepared Retirement Institute's 13F filing for Q2 2026, filed 10 Aug 2026.